Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Phenotype |hepatocellular carcinoma
Sentences 268
PubMedID- 21619694 Similar findings have been reported in previous studies, including hepatocellular carcinoma associated with chronic hepatitis c, gastric carcinoma, and sporadic endometrial carcinoma [49,70,75], suggesting an interaction of mdm2 snp309, infectious factor, and hormone factor.
PubMedID- 24703510 Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis c virus infection.
PubMedID- 22972059 Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 24393884 Case 1 involved a 63-year-old woman who had multiple hepatocellular carcinomas (hcc) associated with hepatitis c virus infection.
PubMedID- 23907815 Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis b.
PubMedID- 22695885 Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis.
PubMedID- 25469280 Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis c virus infection: a prospective study.
PubMedID- 24772876 [concurrent development of non-hodgkin lymphoma and hepatocellular carcinoma in patient with chronic hepatitis c].
PubMedID- 23326737 Fatal hepatocellular carcinoma in a patient with occult hepatitis b virus infection following the administration of r-chop for diffuse large b-cell lymphoma.
PubMedID- 24570913 Do statins reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 20305313 Main indications for orthotopic liver transplantation were cholestatic liver disease (31%), viral-induced cirrhosis (25%), alcoholic liver disease (19%), hepatocellular carcinoma associated with hepatitis virus infection (13%), autoimmune cirrhosis (6%), cryptogenic acute liver failure (6%).
PubMedID- 26052395 Risk for hepatocellular carcinoma in the course of chronic hepatitis b virus infection and the protective effect of therapy with nucleos(t)ide analogues.
PubMedID- 24187458 Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis b.
PubMedID- 20095888 Risk of hepatocellular carcinoma in patients with chronic hepatitis b virus infection.
PubMedID- 22966320 Development of hepatocellular carcinoma in patients with chronic hepatitis c more than 10 years after sustained virological response to interferon therapy.
PubMedID- 22096937 [antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related chronic hepatitis and cirrhosis].
PubMedID- 21677494 We report a case of an 80-year-old male who suffered from intractable hepatic encephalopathy and hepatocellular carcinoma( hcc), associated with hepatitis type c-related liver cirrhosis.
PubMedID- 21129375 Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis c.
PubMedID- 22372460 hepatocellular carcinoma (hcc) in a patient with hepatitis b virus (hbv) infection.
PubMedID- 25702656 Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib.
PubMedID- 23853347 Liver cirrhosis and/or hepatocellular carcinoma develops in 15-40% of chronic hepatitis b virus infected patients without treatment.
PubMedID- 20384529 Objective: the aim of this nationwide cohort study was to assess the risk for hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection or hbv and hepatitis c virus (hcv) co-infection in sweden, a low endemic country.
PubMedID- 26421419 Background: hepatectomy in hepatocellular carcinoma (hcc) patients lead to postoperative hepatitis b virus (hbv) reactivation (phr) as well as immunosuppression.
PubMedID- 24128413 Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis b.
PubMedID- 26140089 Aim: to evaluate the downstaging rates in hepatitis c virus-patients with hepatocellular carcinoma (hcc), treated with degradable starch microspheres transcatheter arterial chemoembolization (dsm-tace), to reach new-milan-criteria (nmc) for transplantation.
PubMedID- 24463696 Influence of human t-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 20981260 A 73-year-old man with a history of hepatocellular carcinoma associated with hepatitis c virus-related cirrhosis was referred to the department of urology because a thickened wall of the urinary bladder was incidentally detected by computed tomography (ct).
PubMedID- 23090836 Role of leptin receptor (lepr) gene polymorphisms and haplotypes in susceptibility to hepatocellular carcinoma in subjects with chronic hepatitis b virus infection.
PubMedID- 22688407 Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in japan.
PubMedID- 26519622 The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis c virus-related cirrhosis.
PubMedID- 25133046 Prevention of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 25331666 [increased risk of hepatocellular carcinoma in patients with chronic hepatitis c.]
PubMedID- 23860735 Genetic variation near interleukin 28b and the risk of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 25736100 Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: possible association with non-b non-c hepatitis pathogenesis.
PubMedID- 21104161 Association of novel mutations and haplotypes in the pres region of hepatitis b virus with hepatocellular carcinoma.
PubMedID- 21278701 The incidence of hepatocellular carcinoma associated with hepatitis c infection decreased in kyushu area.
PubMedID- 26446006 Background and objectives: we studied the effect of achieving sustained virological response (svr) on the risk of developing hepatocellular carcinoma (hcc) in patients with hepatitis c receiving anti-hepatitis c virus treatment.
PubMedID- 21170112 [small hepatocellular carcinoma in patients with hepatitis b-induced cirrhosis: a comparison between mri and mdct].
PubMedID- 26394142 End-stage liver disease and hepatocellular carcinoma due to hepatitis c virus (hcv) infection constitute one of the main indications for liver transplantation (lt) worldwide [1].
PubMedID- 24440974 Selection of reference genes for rt-qpcr analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis b infection and cirrhosis.
PubMedID- 26064707 His medical history was notable for cirrhosis secondary to chronic hepatitis c, complicated by multifocal hepatocellular carcinoma (hcc), which had been lately diagnosed following an episode of obstructive jaundice.
PubMedID- 26380927 The aim of this study was to investigate the feasibility of using serum exosomal micrornas as novel serological biomarkers for hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb).
PubMedID- 25238238 A serum microrna panel as potential biomarkers for hepatocellular carcinoma related with hepatitis b virus.
PubMedID- 25373121 Are selective serotonin reuptake inhibitors associated with hepatocellular carcinoma in patients with hepatitis c.
PubMedID- 23258096 Effect of response to interferon-alpha therapy on the occurrence of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 21160979 Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis b.
PubMedID- 23801839 Perceptions about preventing hepatocellular carcinoma among patients with chronic hepatitis in taiwan.
PubMedID- 24576055 Background & aims: the aim of this study was to re-evaluate the diagnostic performance of alpha-foetoprotein (afp) as a surveillance test for hepatocellular carcinoma (hcc) in patients with hepatitis b virus-related chronic liver disease who were treated with entecavir (etv).
PubMedID- 22819910 Background/aims: we investigated the clinicopathological findings and outcome after surgery for hepatocellular carcinoma in patients without hepatitis b or c virus infection.
PubMedID- 22946841 Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis b or hepatitis c virus by using liquid chromatography-mass spectrometry.

Page: 1 2 3 4 5 6